<?xml version="1.0" encoding="UTF-8"?>
<ref id="b22-ijmm-46-02-0463">
 <label>22</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Skowronski</surname>
    <given-names>DM</given-names>
   </name>
   <name>
    <surname>Sabaiduc</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Leir</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Rose</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Zou</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Murti</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Dickinson</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Olsha</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Gubbay</surname>
    <given-names>JB</given-names>
   </name>
   <name>
    <surname>Croxen</surname>
    <given-names>MA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)</article-title>
  <source>Euro Surveill</source>
  <volume>24</volume>
  <fpage>1900585</fpage>
  <year>2019</year>
  <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2019.24.46.1900585</pub-id>
  <!--<pub-id pub-id-type="pmcid">6864978</pub-id>-->
 </element-citation>
</ref>
